Therefore, the reduced FGF1 induced by miR-326 over-expression could attenuate the activity of PI3K/AKT and MEK 1/2 pathways to inhibit the malignant behaviors of glioma cells. The gene discussed is AKT1; the disease is central nervous system cancer.